Literature DB >> 22380519

Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.

Mi Ryung Roh1, Hyun Joon Shin, Soo Hyun Lee, Kee Yang Chung.   

Abstract

Individuals with a personal history of non-melanoma skin cancer (NMSC) are known to have an increased risk of subsequent cancers. However, most of the studies regarding this fact were done on Caucasian populations. We investigated whether Korean patients with NMSC have an increased risk of developing second cancers compared to the general Korean population. Five hundred and thirty-two patients diagnosed with NMSC at the Department of Dermatology of Yonsei University Health System from 1999 to 2008 were assessed for development of second cancers. The overall second cancer incidence was increased among patients diagnosed with NMSC compared with the general population in Korea: 37 second cancer total (standardized incidence ratio [SIR] 1.38, 95% confidence interval [CI] 1.10-1.90); 23 second cancers in males (SIR 4.24, 95% CI 2.69-6.36); and 14 second cancers in females (SIR 2.28, 95% CI 1.25-3.83). There were significantly increased incidence ratios for NMSC (eight second cancers [SIR 9.52, 95% CI 4.11-18.77]), bladder cancer (four second cancers [SIR 4.21, 95% CI 1.15-10.78]) and nasopharyngeal cancer (one second cancer [SIR 20.00, 95% CI: 1.51-25.33]). Korean patients diagnosed with NMSC had more second cancers, particularly other skin cancers. This study provides additional evidence that NMSC may be a clinically significant and substantial risk factor for second cancers even in a Korean population, in which the incidence of NMSC is much lower than Caucasians.
© 2012 Japanese Dermatological Association.

Entities:  

Mesh:

Year:  2012        PMID: 22380519     DOI: 10.1111/j.1346-8138.2011.01495.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers?

Authors:  Anthony J Alberg; Alexander H Fischer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

2.  Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.

Authors:  Margaret R Karagas; Janet L Peacock; Judy R Rees; M Scot Zens; Maria O Celaya; Bruce L Riddle
Journal:  Int J Cancer       Date:  2015-01-29       Impact factor: 7.396

3.  Non melanoma skin cancer and subsequent cancer risk.

Authors:  Judy R Rees; M Scot Zens; Jiang Gui; Maria O Celaya; Bruce L Riddle; Margaret R Karagas
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.